Tus-pharmaceutical group (000590.SZ): intends to increase capital by 25 million yuan to the traditional chinese medicine company.

Gelonghui November 22nd | Tus-Pharmaceutical Group (000590.SZ) announced that the company plans to use its own funds to increase the capital of its wholly-owned subsidiary Guhan Traditional Chinese Medicine Co., Ltd. (hereinafter referred to as the "traditional chinese medicine company") by 25 million yuan. After the capital increase, the registered capital of the traditional chinese medicine company will increase to 160 million yuan, and the company still holds 100% equity of the traditional chinese medicine company.

Gelonghui FinanceNov 22 18:14

Enlightenment Pharmaceutical: Report for the third quarter of 2024

SZSIOct 30 00:00 · Announcements

Express News | tus-pharmaceutical group: The company's controlling shareholder's shares may be auctioned judicially, and the company's controlling rights may change.

BreakingsOct 29 19:56

Express News | tus-pharmaceutical group: Change in company's controlling ownership may occur.

BreakingsOct 29 19:51

tus-pharmaceutical group (000590.SZ): a net loss of 28.4545 million yuan in the first three quarters.

On October 29th, Gelonhui reported that Tus-Pharmaceutical Group (000590.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.216 billion yuan for the first three quarters, a year-on-year decrease of 21.26%; net income attributable to shareholders of the listed company was -28.4545 million yuan; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was -31.8838 million yuan; and basic earnings per share was -0.1188 yuan.

Gelonghui FinanceOct 29 19:37

Tus-pharmaceutical group (000590.SZ): guangdong Xiantong Pharma currently has no products for the treatment of dengue fever.

According to the investor interaction platform, tus-pharmaceutical group (000590.SZ) stated that its wholly-owned subsidiary, Guangdong Xiantong Pharmaceutical Co., Ltd. currently has no products for the treatment of dengue fever.

Gelonghui FinanceOct 23 15:42